NASDAQReal EstateReit - SpecialtySnapshot 2026-07-31
Reading EQIX? Create a free portfolio, then add this holding for ongoing Reports and tracking. Track it in a free portfolio. No credit card.
Create your account →Daily closes. Earnings/event dots are placed inline.
Industries move in repeating boom-and-bust cycles. This shows where this stock’s industry sits in that cycle, stage by stage (recovery → expansion → supercycle → steady → deceleration → contraction), from its fundamentals (orders, revenue, capital spending), not the stock’s price.
A booming industry is a tailwind for the names in it; a contracting one is a headwind. Companies in the same industry tend to rise and fall together with the cycle, the way a tide lifts and lowers every boat in the harbor at once, so a large part of a stock’s swing can come from where its industry sits rather than from the company itself. It’s context for reading the company’s results, not a buy/sell call. Full explanation →
Real Estate is in steady. Describes the industry's cycle state, not a call on this stock.
The stage band shows the industry’s cycle over the chart’s timeline (each color a stage); a ▼ marks a quarter its growth inflected down — amber is an unconfirmed watch, red is confirmed the next quarter. Use “Overlay cycle on chart” to tint the price chart by stage. The industry’s fundamentals, not a signal on this stock.
Primary pillar under pressure — Annual revenue growth near 10%: revenue +16% vs 10%.
View ThesisRevenue is growing steadily — about 10% over the past year.
View GrowthRanks in the weakest quality tier of its industry — roughly the bottom 42%, softest on free-cash-flow margins.
View QualityManagement screens strong on capital allocation, earnings delivery, margins, market reaction to earnings.
View ManagementExpectations look reasonable — what the market is pricing in sits in line with or below what analysts forecast.
View ValuationModerate volatility — typically moves about 1% a day.
View RiskEquinix's growth in AI and data center capabilities has to keep compounding to justify the price. Revenue grew 16% year over year in Q2 2026, and the company outlined a revenue growth target of 11% to 12% for the year. It trades at 28× P/FFO versus a peer median of 14×, indicating the market is pricing in more growth than is forecast. A specific risk is the potential for EQIX to cut guidance on the next call, with a 22% probability of a miss. Peer multiples imply a price about 21% below where it trades, and this read is provisional.
Trailing returns as of 2026-07-31. EQIX is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Based on 33 analysts currently covering EQIX (as of Jul 2026).
Based on 14 Wall Street analysts offering 12-month price targets for EQIX in the last 4 months.
A consensus fair price across 7 valuation methods, at three horizons. As of 2026-08-01. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus Real Estate (broad) — fair value, gap to price, and forward P/E.
Advances: Expand data center footprint in Nordics via atNorth acquisition
Secures funding for data center expansion in Nordics.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-07-31. EPS is implied from price ÷ P/E. Not investment advice.
Current $1019.28
The last 12 months of price, then the range of analyst 12-month targets from today’s $1019.28.
Analyst ratings and price targets are third-party Wall Street estimates, not QuarterlyIQ’s view. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.
Below average on quality vs scored peers
A second lens on the 12-month fair value: for companies that score high on measured quality (profitability, balance-sheet safety, earnings stability), this read trusts more of today's profit margins instead of averaging them toward their multi-year history the way the headline number does. Shown alongside the fair value above, not in place of it. A diagnostic, not a price target or a buy/sell signal.
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
Advances: Expand revenue by 10-13% annually through 2029
Revenue growth aligns with management's expansion goals.
Advances: Expand revenue by 10-13% annually through 2029
Q2 results support revenue growth target through 2029.
Threatens: Expand revenue by 7% - 10% annually
Q3 guidance disappointment may hinder revenue growth.
Advances: Expand revenue by 7% - 10% annually
Tripling capacity supports revenue growth objective.
Advances: Expand revenue by 7% - 10% annually
Increased demand supports revenue growth objectives.
Advances: Expand revenue by 7% - 10% annually
AI demand supports revenue growth expectations.
Partnership enhances growth potential in AI infrastructure.
